Click on the company or penalty amount for more information on each case. Click on the current parent name to reach the summary page for that parent company.
| Company | Current Parent | Current Parent Industry | Primary Offense Type | Year | Agency | Penalty Amount  |
|---|---|---|---|---|---|---|
| Aventis Pharmaceutical L.P. | Sanofi | pharmaceuticals | False Claims Act and related | 2009 | AL-AG | $14,833,333 |
| Forest Laboratories | AbbVie | pharmaceuticals | False Claims Act and related | 2009 | AL-AG | $14,833,333 |
| Shering-Plough/Warrick Companies | Merck | pharmaceuticals | False Claims Act and related | 2009 | AL-AG | $14,833,333 |
| TEVA Pharmaceuticals USA | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2009 | AL-AG | $14,833,333 |
| Shire US Inc. | Takeda Pharmaceutical | pharmaceuticals | price-fixing or anti-competitive practices | 2016 | private lawsuit-federal | $14,750,000 |
| Aventis Pharmaceuticals | Sanofi | pharmaceuticals | False Claims Act and related | 2019 | IL-AG | $14,708,388 |
| AstraZeneca | AstraZeneca | pharmaceuticals | False Claims Act and related | 2009 | KY-AG | $14,700,000 |
| Pfizer Inc. | Pfizer | pharmaceuticals | off-label or unapproved promotion of medical products | 2011 | FDA | $14,500,000 |
| Mylan Inc. | Viatris | pharmaceuticals | price-fixing or anti-competitive practices | 2020 | private lawsuit-federal | $14,377,600 |
| Merck KgaA | Merck KGaA (EMD) | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | DOJ_ANTITRUST | $14,000,000 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | price-fixing or anti-competitive practices | 2006 | MULTI-AG | $14,000,000 |
| Glenmark Pharmaceuticals | Glenmark Pharmaceuticals | pharmaceuticals | price-fixing or anti-competitive practices | 2023 | private lawsuit-federal | $14,000,000 |
| Glenmark Generics Inc. | Glenmark Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2015 | TX-AG | $13,750,000 |
| Abbott Laboratories | Abbott Laboratories | pharmaceuticals | False Claims Act and related | 2019 | IL-AG | $13,747,929 |
| AbbVie Inc. | AbbVie | pharmaceuticals | False Claims Act and related | 2019 | IL-AG | $13,747,929 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | Boehringer Ingelheim | pharmaceuticals | off-label or unapproved promotion of medical products | 2017 | MULTI-AG | $13,500,000 |
| Allergan, Inc. | AbbVie | pharmaceuticals | price-fixing or anti-competitive practices | 2018 | private lawsuit-federal | $13,450,000 |
| Astellas Pharma US, Inc. | Astellas Pharma | pharmaceuticals | price-fixing or anti-competitive practices | 2016 | private lawsuit-federal | $13,250,000 |
| Sandoz | Sandoz Group | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $13,100,000 |
| Alere Inc. | Abbott Laboratories | pharmaceuticals | accounting fraud or deficiencies | 2017 | SEC | $13,023,885 |
| Eli Lilly and Co. | Eli Lilly | pharmaceuticals | off-label or unapproved promotion of medical products | 2009 | ID-AG | $13,000,000 |
| AstraZeneca Pharmaceuticals LP | AstraZeneca | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $13,000,000 |
| Barr Pharmaceuticals Inc. | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2009 | private lawsuit-federal | $13,000,000 |
| Dr. Reddy's Laboratories | Dr. Reddy's Laboratories | pharmaceuticals | False Claims Act and related | 2022 | TX-AG | $12,900,000 |
| Sandoz, Inc. | Sandoz Group | pharmaceuticals | HHS civil monetary penalties | 2015 | HHSOIG | $12,640,000 |
| Teva Pharmaceuticals USA Inc. | Teva Pharmaceutical Industries | pharmaceuticals | kickbacks and bribery | 2014 | IL-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $12,100,000 |
| Hoechst AG | Sanofi | pharmaceuticals | price-fixing or anti-competitive practices | 2003 | DOJ_ANTITRUST | $12,000,000 |
| Novartis Pharmaceuticals Corporation | Novartis | pharmaceuticals | kickbacks and bribery | 2020 | CA-AG | $11,800,000 |
| Valeant Pharmaceuticals International, Inc. | Bausch Health | pharmaceuticals | price-fixing or anti-competitive practices | 2013 | private lawsuit-federal | $11,750,000 |
| Watson/Schein Pharmaceuticals Inc. | AbbVie | pharmaceuticals | False Claims Act and related | 2011 | TX-AG | $11,300,000 |
| Eisai Inc. | Eisai | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | FDA | $11,000,000 |
| Dava Pharmaceuticals Inc. | Endo International | pharmaceuticals | False Claims Act and related | 2012 | DOJ_CIVIL | $11,000,000 |
| Amgen, Inc. | Amgen | pharmaceuticals | False Claims Act and related | 2013 | MULTI-AG | $11,000,000 |
| Bristol-Myers Squibb | Bristol-Myers Squibb | pharmaceuticals | False Claims Act and related | 2008 | AL-AG | $11,000,000 |
| Dava Pharmaceuticals, Inc. | Endo International | pharmaceuticals | False Claims Act and related | 2012 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $11,000,000 |
| AstraZeneca Pharmaceuticals LP | AstraZeneca | pharmaceuticals | price-fixing or anti-competitive practices | 2013 | private lawsuit-federal | $11,000,000 |
| Hoffmann-La Roche Inc. | Roche | pharmaceuticals | price-fixing or anti-competitive practices | 2008 | private lawsuit-federal | $11,000,000 |
| Pharmavite LLC | Otsuka Pharmaceutical | pharmaceuticals | consumer protection violation | 2017 | private lawsuit-federal | $10,975,000 |
| Bristol-Myers Squibb | Bristol-Myers Squibb | pharmaceuticals | price-fixing or anti-competitive practices | 2022 | private lawsuit-federal | $10,800,000 |
| Aventis Pharmaceuticals Inc. | Sanofi | pharmaceuticals | False Claims Act and related | 2007 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $10,645,600 |
| Alpharma USPD, Inc. and Purepac Pharmaceutical Co. | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2011 | KY-AG | $10,200,000 |
| Biovail Corporation | Bausch Health | pharmaceuticals | accounting fraud or deficiencies | 2008 | SEC | $10,000,000 |
| Boehringer Ingelheim Corp. | Boehringer Ingelheim | pharmaceuticals | False Claims Act and related | 2005 | TX-AG | $10,000,000 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2005 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $10,000,000 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2012 | LA-AG | $10,000,000 |
| Johnson & Johnson | Johnson & Johnson | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $10,000,000 |
| SmithKline Beecham Corp. | GlaxoSmithKline | pharmaceuticals | price-fixing or anti-competitive practices | 2005 | MULTI-AG | $10,000,000 |
| Teva Pharmaceuticals USA Inc., IVAX Corporation, IVAX Pharmaceuticals Inc., Sicor Inc., Barr Laboratories Inc. and Duramed Pharmaceuticals Inc. | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2010 | KY-AG | $10,000,000 |
| Abbott Laboratories | AbbVie | pharmaceuticals | price-fixing or anti-competitive practices | 2009 | private lawsuit-federal | $10,000,000 |
| Bausch & Lomb Inc. | Bausch Health | pharmaceuticals | price-fixing or anti-competitive practices | 2020 | private lawsuit-federal | $10,000,000 |
| Bristol-Myers Squibb Co. | Bristol-Myers Squibb | pharmaceuticals | price-fixing or anti-competitive practices | 2022 | private lawsuit-federal | $10,000,000 |
| Johnson & Johnson | Johnson & Johnson | pharmaceuticals | drug or medical equipment safety violation | 2019 | WA-AG | $9,900,000 |
| CSL Plasma Inc. | CSL Limited | pharmaceuticals | privacy violation | 2022 | private lawsuit-federal | $9,900,000 |
| Ethicon | Johnson & Johnson | pharmaceuticals | consumer protection violation | 2023 | KY-AG | $9,900,000 |
| Abbott Laboratories | AbbVie | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
| Amgen Inc. | Amgen | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
| Aventis Pharmaceuticals Inc. | Sanofi | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
| Dey, Inc. | Viatris | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
| Fujisawa Healthcare, Inc. | Astellas Pharma | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
| Hoechst Marion Roussel | Sanofi | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
| Immunex Corporation | Amgen | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
| Pharmacia Corporation | Pfizer | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
| Watson Pharmaceuticals, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
| ZLB Behring, L.L.C. | CSL Limited | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
| Roxanne Laboratories and Boehringer Ingelheim | Hikma Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2008 | AL-AG | $9,500,000 |
| Pfizer Inc. | Pfizer | pharmaceuticals | drug or medical equipment safety violation | 2014 | NV-AG | $9,500,000 |
| Novo Nordisk A/S | Novo Holdings A/S | pharmaceuticals | kickbacks and bribery | 2009 | DOJ_CRIMINAL | $9,000,000 |
| General Nutrition | Harbin Pharmaceutical Group | pharmaceuticals | wage and hour violation | 2016 | private lawsuit-federal | $9,000,000 |
| Dey, Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2003 | TX-AG | $9,000,000 |
| Mutual Pharmaceutical Company, Inc. | Sun Pharmaceuticals | pharmaceuticals | price-fixing or anti-competitive practices | 2015 | private lawsuit-federal | $9,000,000 |
| UCB Chemicals Corporation | UCB | pharmaceuticals | price-fixing or anti-competitive practices | 2001 | private lawsuit-federal | $9,000,000 |
| Warner Chilcott Holdings Company | AbbVie | pharmaceuticals | price-fixing or anti-competitive practices | 2008 | private lawsuit-federal | $9,000,000 |
| Taro Pharmaceuticals USA, Inc. | Sun Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2014 | TX-AG | $8,750,000 |
| Roxane Laboratories, Inc. | Hikma Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2009 | FL-AG | $8,500,000 |
| Pfizer, Inc. and Pharmacia Corporation | Pfizer | pharmaceuticals | False Claims Act and related | 2010 | HI-AG | $8,200,000 |
| Warner Chilcott | AbbVie | pharmaceuticals | price-fixing or anti-competitive practices | 2015 | private lawsuit-federal | $8,000,000 |
| Akorn Operating Company LLC | Akorn Inc. | pharmaceuticals | False Claims Act and related | 2022 | DOJ_CIVIL | $7,900,000 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | Boehringer Ingelheim | pharmaceuticals | False Claims Act and related | 2010 | WI-AG | $7,750,000 |
| Eisai | Eisai | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | MULTI-AG | $7,634,700 |
| Cephalon Inc. | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2015 | DOJ_CIVIL | $7,500,000 |
| Cephalon, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2015 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $7,500,000 |
| Amgen Inc. | Amgen | pharmaceuticals | False Claims Act and related | 2009 | IL-AG | $7,200,000 |
| Forest Laboratories Inc. | AbbVie | pharmaceuticals | False Claims Act and related | 2019 | IL-AG | $7,089,034 |
| Aventis | Sanofi | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $7,000,000 |
| Janssen Pharmaceutical Products, LP, Centocor, Inc., McNeil Pharmaceutical, Inc., Ortho Biotech Products, LP and Ortho-McNeil Pharmaceutical, Inc. | Johnson & Johnson | pharmaceuticals | False Claims Act and related | 2012 | KY-AG | $7,000,000 |
| Novartis | Novartis | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $7,000,000 |
| Teva Pharmaceutical USA, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2009 | MA-AG | $7,000,000 |
| Abbott Laboratories | AbbVie | pharmaceuticals | False Claims Act and related | 2008 | PA-AG | $6,950,000 |
| Johnson & Johnson Consumer Companies, Inc. | Johnson & Johnson | pharmaceuticals | consumer protection violation | 2017 | private lawsuit-federal | $6,750,000 |
| InterMune Inc. | Roche | pharmaceuticals | off-label or unapproved promotion of medical products | 2006 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $6,700,000 |
| Novartis Pharmaceuticals | Novartis | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | TX-AG | $6,638,250 |
| Mylan Laboratories, Inc. and Mylan Pharmaceuticals, Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2011 | KY-AG | $6,500,000 |
| Teva Pharmaceuticals USA, Inc. et al. | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2010 | HI-AG | $6,500,000 |
| Johnson & Johnson | Johnson & Johnson | pharmaceuticals | consumer protection violation | 2020 | private lawsuit-federal | $6,315,000 |
| Novo Nordisk Inc | Novo Holdings A/S | pharmaceuticals | False Claims Act and related | 2022 | USAO | $6,300,000 |
| Abbott Laboratories | AbbVie | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $6,200,000 |
| Cephalon, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | off-label or unapproved promotion of medical products | 2008 | CT-AG | $6,150,000 |
| Ortho-McNeil Pharmaceutical LLC | Johnson & Johnson | pharmaceuticals | drug or medical equipment safety violation | 2010 | USAO | $6,140,000 |
| Merck and Company | Merck | pharmaceuticals | water pollution violation | 2008 | EPA | $6,075,000 |
| Inspire Pharmaceuticals | Merck | pharmaceuticals | off-label or unapproved promotion of medical products | 2015 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $6,000,000 |
| Merck Sharp & Dohme Corp. | Merck | pharmaceuticals | False Claims Act and related | 2012 | KY-AG | $6,000,000 |
